1. Home
  2. BNR vs BDL Comparison

BNR vs BDL Comparison

Compare BNR & BDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$9.36

Market Cap

76.5M

Sector

Health Care

ML Signal

HOLD

Logo Flanigan's Enterprises Inc.

BDL

Flanigan's Enterprises Inc.

HOLD

Current Price

$45.80

Market Cap

83.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNR
BDL
Founded
2014
1959
Country
China
United States
Employees
N/A
N/A
Industry
Medical Specialities
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
76.5M
83.3M
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
BNR
BDL
Price
$9.36
$45.80
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
20.8K
5.4K
Earning Date
06-05-2026
05-18-2026
Dividend Yield
N/A
1.90%
EPS Growth
N/A
49.72
EPS
N/A
1.98
Revenue
N/A
$205,248,000.00
Revenue This Year
$111.65
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$22.07
Revenue Growth
N/A
8.99
52 Week Low
$3.51
$26.33
52 Week High
$41.72
$47.99

Technical Indicators

Market Signals
Indicator
BNR
BDL
Relative Strength Index (RSI) 51.80 61.45
Support Level $8.05 $29.14
Resistance Level $13.89 $47.99
Average True Range (ATR) 0.85 2.37
MACD 0.55 -0.07
Stochastic Oscillator 90.32 62.15

Price Performance

Historical Comparison
BNR
BDL

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

About BDL Flanigan's Enterprises Inc.

Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.

Share on Social Networks: